BetterScholar BetterScholar
9
Role
Title
Level Year L/R
🐜 Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
31 auth. Sara De Brouwer, K. De Preter, C. Kumps, P. Zabrocki, Michaël Porcu, E. M. Westerhout, Arjan Lakeman, J. Vandesompele, J. Hoebeeck, T. Van Maerken, A. De Paepe, G. Laureys, J. Schulte, A. Schramm, C. van den Broecke, ... Joëlle Vermeulen, N. Van Roy, K. Beiske, M. Renard, R. Noguera, O. Delattre, I. Janoueix-Lerosey, P. Kogner, T. Martinsson, A. Nakagawara, M. Ohira, H. Caron, A. Eggert, J. Cools, R. Versteeg, F. Speleman
8 2010
8
🐜
🦁 Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma.
12 auth. T. Van Maerken, F. Speleman, Joëlle Vermeulen, I. Lambertz, S. De Clercq, Els De Smet, ... N. Yigit, V. Coppens, J. Philippé, A. De Paepe, J. Marine, J. Vandesompele
7 2006
7
🦁
🦁 Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
15 auth. T. Van Maerken, L. Ferdinande, J. Taildeman, I. Lambertz, N. Yigit, L. Vercruysse, A. Rihani, M. Michaelis, J. Cinatl, C. Cuvelier, ... J. Marine, A. De Paepe, M. Bracke, F. Speleman, J. Vandesompele
6 2009
6
🦁
🐜 Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
16 auth. Anneleen Decock, M. Ongenaert, J. Hoebeeck, K. De Preter, Gert Van Peer, W. van Criekinge, R. Ladenstein, J. Schulte, R. Noguera, R. Stallings, ... An Van Damme, G. Laureys, Joëlle Vermeulen, T. Van Maerken, F. Speleman, J. Vandesompele
6 2012
6
🐜
🐜 Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment
31 auth. I. Lambertz, C. Kumps, Shana Claeys, S. Lindner, A. Beckers, E. Janssens, Daniel R. Carter, A. Cazes, B. Cheung, Marilena De Mariano, A. de Bondt, Sara De Brouwer, O. Delattre, J. Gibbons, I. Janoueix-Lerosey, ... G. Laureys, C. Liang, Glenn M Marchall, Michaël Porcu, J. Takita, David Camacho Trujillo, Ilse van den Wyngaert, N. Van Roy, Alan Van Goethem, T. Van Maerken, P. Zabrocki, J. Cools, J. Schulte, J. Vialard, F. Speleman, K. De Preter
6 2015
6
🐜
🦁 Functional Analysis of the p53 Pathway in Neuroblastoma Cells Using the Small-Molecule MDM2 Antagonist Nutlin-3
10 auth. T. Van Maerken, A. Rihani, D. Dreidax, S. De Clercq, N. Yigit, J. Marine, ... F. Westermann, A. De Paepe, J. Vandesompele, F. Speleman
6 2011
6
🦁
🐜 Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
210 auth. Karoline B. Kuchenbaecker, S. Neuhausen, M. Robson, D. Barrowdale, L. McGuffog, A. Mulligan, I. Andrulis, A. Spurdle, M. Schmidt, R. Schmutzler, C. Engel, B. Wappenschmidt, H. Nevanlinna, M. Thomassen, M. Southey, ... P. Radice, S. Ramus, S. Domchek, K. Nathanson, Andrew Lee, S. Healey, R. Nussbaum, T. Rebbeck, B. Arun, P. James, B. Karlan, J. Lester, I. Cass, Breast Cancer Family Registry, M. Terry, M. Daly, D. Goldgar, S. Buys, R. Janavicius, L. Tihomirova, N. Tung, C. M. Dorfling, E. J. van Rensburg, L. Steele, Thomas v O Hansen, B. Ejlertsen, A. Gerdes, F. Nielsen, J. Dennis, J. Cunningham, S. Hart, S. Slager, A. Osorio, J. Benítez, M. Durán, J. Weitzel, I. Tafur, M. Hander, P. Peterlongo, S. Manoukian, B. Peissel, G. Roversi, G. Scuvera, B. Bonanni, P. Mariani, S. Volorio, R. Dolcetti, L. Varesco, L. Papi, M. Tibiletti, G. Giannini, F. Fostira, I. Konstantopoulou, J. Garber, U. Hamann, A. Donaldson, C. Brewer, Claire Foo, D. Evans, D. Frost, D. Eccles, F. Douglas, A. Brady, J. Cook, M. Tischkowitz, J. Adlard, J. Barwell, K. Ong, L. Walker, L. Izatt, L. Side, M. Kennedy, M. Rogers, M. Porteous, P. Morrison, Radka Platte, R. Eeles, R. Davidson, S. Hodgson, Steve Ellis, A. Godwin, K. Rhiem, A. Meindl, N. Ditsch, N. Arnold, H. Plendl, D. Niederacher, C. Sutter, D. Steinemann, Nadja Bogdanova-Markov, K. Kast, R. Varon‐Mateeva, S. Wang-gohrke, A. Gehrig, B. Markiefka, B. Buecher, C. Lefol, D. Stoppa-Lyonnet, E. Rouleau, F. Prieur, F. Damiola, L. Barjhoux, L. Faivre, M. Longy, N. Sevenet, O. Sinilnikova, S. Mazoyer, V. Bonadona, V. Caux‐Moncoutier, C. Isaacs, T. Van Maerken, K. Claes, M. Piedmonte, L. Andrews, J. Hays, G. Rodriguez, T. Caldés, M. de la Hoya, Sofia Khan, F. Hogervorst, C. Aalfs, J. de Lange, H. Meijers-Heijboer, A. H. van der Hout, J. Wijnen, Kep van Roozendaal, A. Mensenkamp, A. V. D. van den Ouweland, C. V. van Deurzen, R. B. van der Luijt, E. Oláh, O. Díez, C. Lázaro, I. Blanco, A. Teule, M. Menéndez, A. Jakubowska, J. Lubiński, C. Cybulski, J. Gronwald, Katarzyna Jaworska–Bieniek, K. Durda, A. Arason, C. Maugard, P. Soucy, M. Montagna, S. Agata, M. Teixeira, Curtis L. Olswold, N. Lindor, V. Pankratz, Emily J. Hallberg, Xianshu Wang, C. Szabo, J. Vijai, Lauren M. Jacobs, M. Corines, Anne Lincoln, A. Berger, A. Fink-Retter, C. Singer, C. Rappaport, Daphne Geschwantler Kaulich, G. Pfeiler, M. Tea, C. Phelan, P. Mai, M. Greene, G. Rennert, E. Imyanitov, G. Glendon, A. Toland, A. Bojesen, I. Pedersen, U. Jensen, M. Caligo, E. Friedman, R. Berger, Y. Laitman, Johanna Rantala, B. Arver, N. Loman, Å. Borg, H. Ehrencrona, O. Olopade, J. Simard, D. Easton, G. Chenevix-Trench, K. Offit, F. Couch, A. Antoniou, Embrace Study, Gemo Study Collaborators, Hebon, kConFab investigators
5 2014
5
🐜
🐜 Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic Compounds
8 auth. K. De Preter, Sara De Brouwer, T. Van Maerken, F. Pattyn, A. Schramm, A. Eggert, ... J. Vandesompele, F. Speleman
5 2009
5
🐜
🐜 The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy
9 auth. N. Van Roy, K. De Preter, J. Hoebeeck, T. Van Maerken, F. Pattyn, P. Mestdagh, ... Joëlle Vermeulen, J. Vandesompele, F. Speleman
5 2009
5
🐜